SlideShare ist ein Scribd-Unternehmen logo
1 von 7
Downloaden Sie, um offline zu lesen
Infection Prevention
and Control (IPC)
for Novel Coronavirus
(COVID-19)
WHO IPC Technical and Clinical Unit
Module 2: The novel coronavirus (COVID-19)
Its epidemiology, risk factors, definitions and symptomology
What is a novel coronavirus?
• Coronaviruses (CoV) are a large family of
viruses that cause a wide range of illness
from the common cold to more severe
diseases
• i.e., Middle East Respiratory Syndrome [MERS]
and Severe Acute Respiratory Syndrome
[SARS]
• A novel coronavirus (nCoV) is a new strain
that has not been previously identified in
humans.
What is a novel coronavirus?
• Coronaviruses (CoV) are a large family of viruses that cause a
wide range of illness from the common cold to more severe
diseases. They are often zoonotic.
• I.e., Middle East Respiratory Syndrome [MERS] and Severe Acute
Respiratory Syndrome [SARS]
• Several known coronaviruses are circulating in animals that have not
yet infected humans.
• On 31 December 2019, the WHO China Country Office was
informed of pneumonia cases of unknown cause in Wuhan
City, Hubei Province of China. A novel coronavirus (COVID-
19) was isolated and identified as the causative virus by
Chinese authorities on 7 January.
Countries affected
(as of 23-02-2020)
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/
•Incubation period - current estimates of the incubation period of the virus range:
1-12.5 days (median 5-6 days).
•Estimates will be refined as more data become available.
•More information needed to determine whether transmission can occur from
asymptomatic individuals or during the incubation period.
•Modes of transmission: droplets sprayed by affected individuals, contact with
patient respiratory secretions, contaminated surfaces and equipment.
•Transmission from animals and human-to-human.
•Currently there is no available treatment or vaccination, and only supportive
measures are being recommended.
What we know about COVID-19
COVID-19 signs and symptoms
Illness seems to start
Severe acute respiratory infection (SARI):
A. History of fever, cough, and requiring admission to hospital,
(with no other etiology that fully explains the clinical presentation)
AND
history of travel or residence in/to China in the 14 days
prior to symptom onset
Case definitions – (as of 04-02-2020)
to be investigated and tested
B. Patient with any acute respiratory illness AND at least one of the
following during the 14 days prior to symptom onset:
Contact with a confirmed or suspected case of COVID-19 infection
OR
worked in or attended a health care facility where patients with
confirmed or probable COVID-19 acute respiratory disease
patients were being treated
OR

Weitere ähnliche Inhalte

Was ist angesagt?

Was ist angesagt? (20)

Coronavirus Disease 2019 (COVID-19)
Coronavirus Disease 2019 (COVID-19)Coronavirus Disease 2019 (COVID-19)
Coronavirus Disease 2019 (COVID-19)
 
WHO COVID-19 Guidelines
WHO COVID-19 GuidelinesWHO COVID-19 Guidelines
WHO COVID-19 Guidelines
 
Covid 19-book
Covid 19-bookCovid 19-book
Covid 19-book
 
The Sky Gets Dark Slowly in View of the Emergence of “The Super Omicron Varia...
The Sky Gets Dark Slowly in View of the Emergence of “The Super Omicron Varia...The Sky Gets Dark Slowly in View of the Emergence of “The Super Omicron Varia...
The Sky Gets Dark Slowly in View of the Emergence of “The Super Omicron Varia...
 
WEBINAR REPLAY: One Year On: COVID-19, Rapid Testing, Vaccines, and a Return ...
WEBINAR REPLAY: One Year On: COVID-19, Rapid Testing, Vaccines, and a Return ...WEBINAR REPLAY: One Year On: COVID-19, Rapid Testing, Vaccines, and a Return ...
WEBINAR REPLAY: One Year On: COVID-19, Rapid Testing, Vaccines, and a Return ...
 
Covid 19 ppt
Covid 19  pptCovid 19  ppt
Covid 19 ppt
 
Covid 19 - the Corona Virus Medical Whitepaper
Covid 19 - the Corona Virus Medical WhitepaperCovid 19 - the Corona Virus Medical Whitepaper
Covid 19 - the Corona Virus Medical Whitepaper
 
Evidance based managment of COVID-19 patients
Evidance based managment of COVID-19 patientsEvidance based managment of COVID-19 patients
Evidance based managment of COVID-19 patients
 
Coronavirus
CoronavirusCoronavirus
Coronavirus
 
Corona in children third wave
Corona in children third waveCorona in children third wave
Corona in children third wave
 
COVID-19 (Coronavirus disease 2019) update
COVID-19 (Coronavirus disease 2019) updateCOVID-19 (Coronavirus disease 2019) update
COVID-19 (Coronavirus disease 2019) update
 
Covi19 updates 2021
Covi19 updates 2021Covi19 updates 2021
Covi19 updates 2021
 
Covid19 by likhit
Covid19  by likhitCovid19  by likhit
Covid19 by likhit
 
Coronavirus presentation
Coronavirus presentationCoronavirus presentation
Coronavirus presentation
 
Journal clinical characteristics covid 19
Journal clinical characteristics  covid 19Journal clinical characteristics  covid 19
Journal clinical characteristics covid 19
 
An overview on coronavirus (COVID-19)
An overview on coronavirus (COVID-19)An overview on coronavirus (COVID-19)
An overview on coronavirus (COVID-19)
 
Coronavirus FAQ : Covid-19
Coronavirus FAQ : Covid-19Coronavirus FAQ : Covid-19
Coronavirus FAQ : Covid-19
 
Covid19 prevention and control analysis
Covid19 prevention and control analysisCovid19 prevention and control analysis
Covid19 prevention and control analysis
 
Covid 19 surveillance
Covid 19 surveillanceCovid 19 surveillance
Covid 19 surveillance
 
Corona virus
Corona virusCorona virus
Corona virus
 

Ähnlich wie COVID-19 Infection Prevention and Control (IPC)

2 Updated COVID 19 introduction V21.pptx
2 Updated COVID 19 introduction V21.pptx2 Updated COVID 19 introduction V21.pptx
2 Updated COVID 19 introduction V21.pptx
marrahmohamed33
 
Sars Covid by Dr.Manoj.pptx
Sars Covid by Dr.Manoj.pptxSars Covid by Dr.Manoj.pptx
Sars Covid by Dr.Manoj.pptx
Manoj Aryal
 

Ähnlich wie COVID-19 Infection Prevention and Control (IPC) (20)

Covid 19 Dr. MADHUKIRAN, MD.PULMONOLOGY
Covid 19 Dr. MADHUKIRAN, MD.PULMONOLOGYCovid 19 Dr. MADHUKIRAN, MD.PULMONOLOGY
Covid 19 Dr. MADHUKIRAN, MD.PULMONOLOGY
 
Lecture 3 COVID 19.pdf
Lecture 3  COVID 19.pdfLecture 3  COVID 19.pdf
Lecture 3 COVID 19.pdf
 
2019 Novel Coronavirus
2019 Novel Coronavirus2019 Novel Coronavirus
2019 Novel Coronavirus
 
Coronavirus (COVID-19)
Coronavirus (COVID-19) Coronavirus (COVID-19)
Coronavirus (COVID-19)
 
Covid
CovidCovid
Covid
 
Coronavirus Disease (COVID)-19 Outbeak
Coronavirus Disease (COVID)-19 OutbeakCoronavirus Disease (COVID)-19 Outbeak
Coronavirus Disease (COVID)-19 Outbeak
 
Corona
Corona Corona
Corona
 
Public health surveillance of covid 19
Public health surveillance of covid 19Public health surveillance of covid 19
Public health surveillance of covid 19
 
Novel corona virus (n cov 2019)
Novel corona virus (n cov  2019)Novel corona virus (n cov  2019)
Novel corona virus (n cov 2019)
 
2 Updated COVID 19 introduction V21.pptx
2 Updated COVID 19 introduction V21.pptx2 Updated COVID 19 introduction V21.pptx
2 Updated COVID 19 introduction V21.pptx
 
Dethroning CORONA virus
Dethroning CORONA virusDethroning CORONA virus
Dethroning CORONA virus
 
Presentation on COVID-19 in March 2020
Presentation on COVID-19 in March 2020Presentation on COVID-19 in March 2020
Presentation on COVID-19 in March 2020
 
COVID 19-De pope.pdf
COVID 19-De pope.pdfCOVID 19-De pope.pdf
COVID 19-De pope.pdf
 
Covid 19-ppt
Covid 19-pptCovid 19-ppt
Covid 19-ppt
 
Sars Covid by Dr.Manoj.pptx
Sars Covid by Dr.Manoj.pptxSars Covid by Dr.Manoj.pptx
Sars Covid by Dr.Manoj.pptx
 
covid-19 corona virus
covid-19 corona virus covid-19 corona virus
covid-19 corona virus
 
Covid 19 by Dr akbar safi
Covid 19 by Dr akbar safiCovid 19 by Dr akbar safi
Covid 19 by Dr akbar safi
 
Covid 19
Covid 19  Covid 19
Covid 19
 
Corona virus
Corona virus Corona virus
Corona virus
 
Novel coronavirus outbreak
Novel coronavirus outbreakNovel coronavirus outbreak
Novel coronavirus outbreak
 

Mehr von Updesh Yadav

Mehr von Updesh Yadav (20)

X-Rays with well labelled parts
X-Rays with well labelled partsX-Rays with well labelled parts
X-Rays with well labelled parts
 
COVID-19 How to calculate Reproduction Number (Ro)
COVID-19 How to calculate Reproduction Number (Ro)COVID-19 How to calculate Reproduction Number (Ro)
COVID-19 How to calculate Reproduction Number (Ro)
 
COVID-19 When to use a Surgical Face Mask or FFP3 Respirator
COVID-19 When to use a Surgical Face Mask or FFP3 RespiratorCOVID-19 When to use a Surgical Face Mask or FFP3 Respirator
COVID-19 When to use a Surgical Face Mask or FFP3 Respirator
 
COVID-19 Overview
COVID-19 OverviewCOVID-19 Overview
COVID-19 Overview
 
COVID-19 Management of a suspected case of COVID-19
COVID-19 Management of a suspected case of COVID-19COVID-19 Management of a suspected case of COVID-19
COVID-19 Management of a suspected case of COVID-19
 
COVID-19 Guidance for Stay at Home
COVID-19 Guidance for Stay at HomeCOVID-19 Guidance for Stay at Home
COVID-19 Guidance for Stay at Home
 
COVID-19 Guidance for Social-distancing
COVID-19 Guidance for Social-distancingCOVID-19 Guidance for Social-distancing
COVID-19 Guidance for Social-distancing
 
COVID-19 Guidance for Primary Care
COVID-19 Guidance for Primary CareCOVID-19 Guidance for Primary Care
COVID-19 Guidance for Primary Care
 
COVID-19 Guidance for Investigation & Clinical Case Management
COVID-19 Guidance for Investigation & Clinical Case ManagementCOVID-19 Guidance for Investigation & Clinical Case Management
COVID-19 Guidance for Investigation & Clinical Case Management
 
COVID-19 Guidance for Infection Prevention & Control in Healthcare Settings
COVID-19 Guidance for Infection Prevention & Control in Healthcare SettingsCOVID-19 Guidance for Infection Prevention & Control in Healthcare Settings
COVID-19 Guidance for Infection Prevention & Control in Healthcare Settings
 
COVID-19 8 Pillars of Response Planning & Initial Actions to be taken by the ...
COVID-19 8 Pillars of Response Planning & Initial Actions to be taken by the ...COVID-19 8 Pillars of Response Planning & Initial Actions to be taken by the ...
COVID-19 8 Pillars of Response Planning & Initial Actions to be taken by the ...
 
Muscle Attachment Table (Compartment Wise)
Muscle Attachment Table (Compartment Wise)Muscle Attachment Table (Compartment Wise)
Muscle Attachment Table (Compartment Wise)
 
National Immunization Schedule (Nepal)
National Immunization Schedule (Nepal)National Immunization Schedule (Nepal)
National Immunization Schedule (Nepal)
 
Congenital Anomalies
Congenital AnomaliesCongenital Anomalies
Congenital Anomalies
 
History Taking
History TakingHistory Taking
History Taking
 
Neglected Tropical Diseases (NTDs)
Neglected Tropical Diseases (NTDs)Neglected Tropical Diseases (NTDs)
Neglected Tropical Diseases (NTDs)
 
Major Neglected Tropical Diseases (NTD)
Major Neglected Tropical Diseases (NTD)Major Neglected Tropical Diseases (NTD)
Major Neglected Tropical Diseases (NTD)
 
Immunoglobulins (Ig)
Immunoglobulins (Ig)Immunoglobulins (Ig)
Immunoglobulins (Ig)
 
History taking a complete guide for all systems (clinical history & examinati...
History taking a complete guide for all systems (clinical history & examinati...History taking a complete guide for all systems (clinical history & examinati...
History taking a complete guide for all systems (clinical history & examinati...
 
History Taking (System Wise) - Elsevier Health
History Taking (System Wise) - Elsevier HealthHistory Taking (System Wise) - Elsevier Health
History Taking (System Wise) - Elsevier Health
 

Kürzlich hochgeladen

Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
ZurliaSoop
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
QucHHunhnh
 

Kürzlich hochgeladen (20)

How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docx
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
Dyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptxDyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptx
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 

COVID-19 Infection Prevention and Control (IPC)

  • 1. Infection Prevention and Control (IPC) for Novel Coronavirus (COVID-19) WHO IPC Technical and Clinical Unit Module 2: The novel coronavirus (COVID-19) Its epidemiology, risk factors, definitions and symptomology
  • 2. What is a novel coronavirus? • Coronaviruses (CoV) are a large family of viruses that cause a wide range of illness from the common cold to more severe diseases • i.e., Middle East Respiratory Syndrome [MERS] and Severe Acute Respiratory Syndrome [SARS] • A novel coronavirus (nCoV) is a new strain that has not been previously identified in humans.
  • 3. What is a novel coronavirus? • Coronaviruses (CoV) are a large family of viruses that cause a wide range of illness from the common cold to more severe diseases. They are often zoonotic. • I.e., Middle East Respiratory Syndrome [MERS] and Severe Acute Respiratory Syndrome [SARS] • Several known coronaviruses are circulating in animals that have not yet infected humans. • On 31 December 2019, the WHO China Country Office was informed of pneumonia cases of unknown cause in Wuhan City, Hubei Province of China. A novel coronavirus (COVID- 19) was isolated and identified as the causative virus by Chinese authorities on 7 January.
  • 4. Countries affected (as of 23-02-2020) https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/
  • 5. •Incubation period - current estimates of the incubation period of the virus range: 1-12.5 days (median 5-6 days). •Estimates will be refined as more data become available. •More information needed to determine whether transmission can occur from asymptomatic individuals or during the incubation period. •Modes of transmission: droplets sprayed by affected individuals, contact with patient respiratory secretions, contaminated surfaces and equipment. •Transmission from animals and human-to-human. •Currently there is no available treatment or vaccination, and only supportive measures are being recommended. What we know about COVID-19
  • 6. COVID-19 signs and symptoms Illness seems to start
  • 7. Severe acute respiratory infection (SARI): A. History of fever, cough, and requiring admission to hospital, (with no other etiology that fully explains the clinical presentation) AND history of travel or residence in/to China in the 14 days prior to symptom onset Case definitions – (as of 04-02-2020) to be investigated and tested B. Patient with any acute respiratory illness AND at least one of the following during the 14 days prior to symptom onset: Contact with a confirmed or suspected case of COVID-19 infection OR worked in or attended a health care facility where patients with confirmed or probable COVID-19 acute respiratory disease patients were being treated OR